Clinical Trial Update: Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy [Phase 4]

View source ↗

Summary

Phase 4 study examining how spironolactone affects autoregulation of the glomerular filtration rate in patients with Type 1 diabetes and hypertension; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 1 Diabetes Mellitus

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Hypertension | Phase 4 | Status: COMPLETED